Cargando…

Comparison of in vivo Efficacy of Hypoxic Cytotoxin Tirapazamine and Hypoxic Cell Radiosensitizer KU‐2285 in Combination with Single and Fractionated Irradiation

Development of strategies to eradicate radioresistant hypoxic cells would be of great benefit for clinical radiotherapy. In the present study, the in vivo effects of a promising hypoxic cytotoxin, tirapazamine (3‐amino‐1,2,4‐benzotriazine 1,4‐di‐N‐oxide), were examined in comparison with those of KU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shibata, Toru, Shibamoto, Yuta, Sasai, Keisuke, Oya, Natsuo, Murata, Rumi, Takagi, Takehisa, Hiraoka, Masahiro, Abe, Mitsuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1996
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920986/ https://www.ncbi.nlm.nih.gov/pubmed/8609056 http://dx.doi.org/10.1111/j.1349-7006.1996.tb00206.x

Ejemplares similares

A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy.
por: Shibamoto, Y., et al.
Publicado: (1997)

A New, Potent 2‐Nitroimidazole Nucleoside Hypoxic Cell Radiosensitizer, RP170
por: Sasai, Keisuke, et al.
Publicado: (1989)

Radiosensitizers of Hypoxic Cells
por: Nias, A. H. W.
Publicado: (1980)

Electronic structure and reactivity of tirapazamine as a radiosensitizer
por: Romero, José, et al.
Publicado: (2021)

Changes in Cell Proliferative Parameters of SCCVII and EMT6 Murine Tumors after Single‐dose Irradiation
por: Murata, Rumi, et al.
Publicado: (1996)

Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins
por: Rashed, Faisal Bin, et al.
Publicado: (2021)

Detection of Hypoxic Cells in Murine Tumors Using the Comet Assay: Comparison with a Conventional Radiobiological Assay
por: Shibuya, Keiko, et al.
Publicado: (1999)

Comparative studies of hypoxic-cell radiosensitization using artificially hypoxic skin in vivo.
por: Denekamp, J., et al.
Publicado: (1982)

Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells
por: de Mey, Sven, et al.
Publicado: (2020)

Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.
por: Siim, B. G., et al.
Publicado: (1996)

Release from the Crabtree effect by hypoxic cell radiosensitizers.
por: Mustea, I., et al.
Publicado: (1979)

Targeting the Tumour Vasculature: Exploitation of Low Oxygenation and Sensitivity to NOS Inhibition by Treatment with a Hypoxic Cytotoxin
por: Baker, Jennifer H. E., et al.
Publicado: (2013)

Effect of lipophilicity of nitroimidazoles on radiosensitization of hypoxic bacterial cells in vitro.
por: Anderson, R. F., et al.
Publicado: (1979)

Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
por: Brown, J. M., et al.
Publicado: (1979)

Repurposing Sulfasalazine as a Radiosensitizer in Hypoxic Human Colorectal Cancer
por: Kerkhove, Lisa, et al.
Publicado: (2023)

Modest radiosensitization of solid tumours in C3H mice by the hypoxic cell radiosensitizer NDPP.
por: Sheldon, P. W., et al.
Publicado: (1975)

Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours.
por: Shibamoto, Y., et al.
Publicado: (1996)

Tirapazamine-cisplatin: the synergy.
por: Gatzemeier, U., et al.
Publicado: (1998)

Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
por: Astor, M., et al.
Publicado: (1979)

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
por: Bibby, Becky A. S., et al.
Publicado: (2021)

Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma
por: Gao, Ruoling, et al.
Publicado: (2022)

Enhanced Cell Killing by Overexpression of Dominant‐negative Phosphatidylinositol 3‐Kinase Subunit, Δp85, Following Genotoxic Stresses
por: Tachiiri, Seiji, et al.
Publicado: (2000)

A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
por: Abratt, R. P.
Publicado: (1982)

Human studies with "high dose" metronidazole: a non-toxic radiosensitizer of hypoxic cells.
por: Deutsch, G., et al.
Publicado: (1975)

Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.
por: Sheldon, P. W., et al.
Publicado: (1977)

Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions
por: Bache, Matthias, et al.
Publicado: (2011)

Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy
por: Hua, Lei, et al.
Publicado: (2018)

Inhibition of Phosphoglycerate Dehydrogenase Radiosensitizes Human Colorectal Cancer Cells under Hypoxic Conditions
por: Van de Gucht, Melissa, et al.
Publicado: (2022)

2285 Patient navigation training: Community-engaged workforce development
por: Ahuja, Nirmal, et al.
Publicado: (2018)

Hypoxic Microenvironment and Metastatic Bone Disease
por: Hiraga, Toru
Publicado: (2018)

NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line
por: Saunders, M P, et al.
Publicado: (2000)

Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro.
por: Stratford, I. J., et al.
Publicado: (1981)

Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-9963) in dogs
por: White, R. A. S., et al.
Publicado: (1980)

Synthesis, in vitro aerobic and hypoxic cytotoxicity and radiosensitizing activity of novel metronidazole tethered 5-fluorouracil
por: Abdi, Khosrou, et al.
Publicado: (2013)

Radiosensitization and Hypoxic Cell Toxicity of NLA‐1 and NLA‐2, Two New Bioreductive Compounds
por: Papadopoulou, Maria V., et al.
Publicado: (1992)

Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption
por: de Mey, Sven, et al.
Publicado: (2018)

Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing
por: Kabakov, Alexander E., et al.
Publicado: (2021)

SESN2 Knockdown Increases Betulinic Acid-Induced Radiosensitivity of Hypoxic Breast Cancer Cells
por: Güttler, Antje, et al.
Publicado: (2022)

Happy Hypoxic
por: Boal, Nina S.
Publicado: (2020)

Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.
por: Workman, P., et al.
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_mrjali10n4qkq70m5qegt1ccef